Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.
AUTOR(ES)
Chalmers, T M
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1031293Documentos Relacionados
- Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.
- Food intolerance in rheumatoid arthritis. II. Clinical and histological aspects.
- Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice.
- Serum gold. II. Levels in rheumatoid arthritis.